[144] Tenaya Therapeutics, Inc. SEC Filing
Tenaya Therapeutics, Inc. (TNYA) filed a Form 144 notice for a proposed sale of 5,053 shares of its common stock through Morgan Stanley Smith Barney Operations Department, with an aggregate market value of $6,331.41. The filing lists total shares outstanding as 162,976,102 and an approximate sale date of 08/18/2025. The securities to be sold were acquired as Restricted Stock Units from the issuer on 08/18/2025, showing an acquired amount of 13,750 units and a payment date of 08/18/2025. The filer reports no sales in the past three months and includes the standard representation about nonpublic material information.
Tenaya Therapeutics, Inc. (TNYA) ha depositato un avviso Form 144 per la proposta di vendita di 5.053 azioni del proprio capitale sociale tramite Morgan Stanley Smith Barney Operations Department, per un valore di mercato complessivo di $6.331,41. Il deposito indica un totale di azioni in circolazione pari a 162.976.102 e una data approssimativa di vendita il 18/08/2025. I titoli da vendere sono stati acquisiti come Restricted Stock Units dall鈥檈mittente in data 18/08/2025, con un ammontare acquisito di 13.750 unit脿 e una data di pagamento il 18/08/2025. Il dichiarante segnala l鈥檃ssenza di vendite negli ultimi tre mesi e include la consueta dichiarazione relativa all鈥檃ssenza di informazioni materiali non pubbliche.
Tenaya Therapeutics, Inc. (TNYA) present贸 un aviso Form 144 para una venta propuesta de 5.053 acciones de su capital social a trav茅s de Morgan Stanley Smith Barney Operations Department, con un valor de mercado agregado de $6.331,41. La presentaci贸n indica un total de acciones en circulaci贸n de 162.976.102 y una fecha aproximada de venta del 18/08/2025. Los valores a venderse fueron adquiridos como Restricted Stock Units del emisor el 18/08/2025, mostrando una cantidad adquirida de 13.750 unidades y una fecha de pago del 18/08/2025. El declarante informa que no ha realizado ventas en los 煤ltimos tres meses e incluye la representaci贸n est谩ndar sobre la ausencia de informaci贸n material no p煤blica.
Tenaya Therapeutics, Inc.(TNYA)電� Morgan Stanley Smith Barney Operations Department毳� 韱淀暣 氤错喌欤� 5,053欤茧ゼ 毵る弰頃� 鞓堨爼鞛勳潉 鞎岆Μ電� Form 144毳� 鞝滌稖頄堨溂氅�, 齑� 鞁滉皜 臧�旃橂姅 $6,331.41鞛呺媹雼�. 鞝滌稖靹滌棎電� 齑� 氚滍枆 欤检嫕 靾橂ゼ 162,976,102欤茧 旮办灛頃橁碃 鞛堨溂氅�, 雽�霝奠爜鞚� 毵る弰 鞓堨爼鞚检潃 2025-08-18搿� 霅橃柎 鞛堨姷雼堧嫟. 毵る弰霅� 歃濌秾鞚� 氚滍枆靷攵�韯� Restricted Stock Units 顺曧儨搿� 2025-08-18鞐� 旆摑霅� 瓴冹溂搿�, 旆摑 靾橂焿鞚� 13,750雼渼鞚搓碃 歆�旮夓澕霃� 2025-08-18鞛呺媹雼�. 鞝滌稖鞛愲姅 斓滉芳 3臧滌洈 雮� 毵る弰 靷嫟鞚� 鞐嗢潓鞚� 氤搓碃頃橁碃 牍勱车臧� 欤检殧 鞝曤炒臧� 鞐嗠嫟電� 響滌 歆勳垹鞚� 韽暔頃橁碃 鞛堨姷雼堧嫟.
Tenaya Therapeutics, Inc. (TNYA) a d茅pos茅 un avis Form 144 concernant une vente propos茅e de 5 053 actions ordinaires via Morgan Stanley Smith Barney Operations Department, pour une valeur marchande totale de 6 331,41 $. Le d茅p么t indique un nombre total d'actions en circulation de 162 976 102 et une date approximative de vente au 18/08/2025. Les titres 脿 vendre ont 茅t茅 acquis sous forme de Restricted Stock Units de l'茅metteur le 18/08/2025, avec un montant acquis de 13 750 unit茅s et une date de paiement le 18/08/2025. Le d茅clarant signale l'absence de ventes au cours des trois derniers mois et inclut la d茅claration standard concernant l'absence d'informations mat茅rielles non publiques.
Tenaya Therapeutics, Inc. (TNYA) hat eine Form-144-Mitteilung f眉r den geplanten Verkauf von 5.053 Stammaktien 眉ber die Morgan Stanley Smith Barney Operations Department eingereicht, mit einem Gesamtmarktwert von $6.331,41. Die Einreichung nennt die insgesamt ausstehenden Aktien mit 162.976.102 und ein ungef盲hres Verkaufsdatum 18.08.2025. Die zu ver盲u脽ernden Wertpapiere wurden am 18.08.2025 als Restricted Stock Units vom Emittenten erworben, der erworbene Betrag betr盲gt 13.750 Einheiten und das Zahlungsdatum ist 18.08.2025. Der Meldende berichtet 眉ber keine Verk盲ufe in den letzten drei Monaten und f眉gt die 眉bliche Erkl盲rung zur Abwesenheit nicht枚ffentlicher, wesentlicher Informationen bei.
- Form 144 filed to disclose proposed sale, satisfying Rule 144 reporting requirements
- Securities originate from Restricted Stock Units, and acquisition/payment dates are stated
- Filer and issuer identifying information are not provided in the content supplied
- No context on filer relationship or trading plan dates is included, limiting governance transparency
Insights
TL;DR: Small planned sale of RSU-derived shares filed under Rule 144; minimal market impact expected based on stated quantities.
The Form 144 discloses a proposed brokered sale of 5,053 common shares with an aggregate market value of $6,331.41, originating from 13,750 restricted stock units granted and acquired on 08/18/2025. The filing confirms no reported sales in the prior three months and lists total outstanding shares as 162,976,102. This notice is procedural under Rule 144 to permit public resale and includes the required representation about material nonpublic information. There are no earnings, debt, or other financial metrics provided in this filing to assess broader company financials.
TL;DR: Form 144 documents an insider or affiliate resale plan step; disclosure is routine and complies with Rule 144 formality.
The filing identifies the securities as acquired via issuer-granted restricted stock units and signals intent to sell through Morgan Stanley Smith Barney. The document contains the standard attestation that the seller is unaware of undisclosed material adverse information. No information about the filer identity, specific insider role, or any trading plan dates is provided in the content. As presented, the notice fulfills Rule 144 reporting requirements but provides limited governance context due to omitted filer and issuer identifying details in the submitted content.
Tenaya Therapeutics, Inc. (TNYA) ha depositato un avviso Form 144 per la proposta di vendita di 5.053 azioni del proprio capitale sociale tramite Morgan Stanley Smith Barney Operations Department, per un valore di mercato complessivo di $6.331,41. Il deposito indica un totale di azioni in circolazione pari a 162.976.102 e una data approssimativa di vendita il 18/08/2025. I titoli da vendere sono stati acquisiti come Restricted Stock Units dall鈥檈mittente in data 18/08/2025, con un ammontare acquisito di 13.750 unit脿 e una data di pagamento il 18/08/2025. Il dichiarante segnala l鈥檃ssenza di vendite negli ultimi tre mesi e include la consueta dichiarazione relativa all鈥檃ssenza di informazioni materiali non pubbliche.
Tenaya Therapeutics, Inc. (TNYA) present贸 un aviso Form 144 para una venta propuesta de 5.053 acciones de su capital social a trav茅s de Morgan Stanley Smith Barney Operations Department, con un valor de mercado agregado de $6.331,41. La presentaci贸n indica un total de acciones en circulaci贸n de 162.976.102 y una fecha aproximada de venta del 18/08/2025. Los valores a venderse fueron adquiridos como Restricted Stock Units del emisor el 18/08/2025, mostrando una cantidad adquirida de 13.750 unidades y una fecha de pago del 18/08/2025. El declarante informa que no ha realizado ventas en los 煤ltimos tres meses e incluye la representaci贸n est谩ndar sobre la ausencia de informaci贸n material no p煤blica.
Tenaya Therapeutics, Inc.(TNYA)電� Morgan Stanley Smith Barney Operations Department毳� 韱淀暣 氤错喌欤� 5,053欤茧ゼ 毵る弰頃� 鞓堨爼鞛勳潉 鞎岆Μ電� Form 144毳� 鞝滌稖頄堨溂氅�, 齑� 鞁滉皜 臧�旃橂姅 $6,331.41鞛呺媹雼�. 鞝滌稖靹滌棎電� 齑� 氚滍枆 欤检嫕 靾橂ゼ 162,976,102欤茧 旮办灛頃橁碃 鞛堨溂氅�, 雽�霝奠爜鞚� 毵る弰 鞓堨爼鞚检潃 2025-08-18搿� 霅橃柎 鞛堨姷雼堧嫟. 毵る弰霅� 歃濌秾鞚� 氚滍枆靷攵�韯� Restricted Stock Units 顺曧儨搿� 2025-08-18鞐� 旆摑霅� 瓴冹溂搿�, 旆摑 靾橂焿鞚� 13,750雼渼鞚搓碃 歆�旮夓澕霃� 2025-08-18鞛呺媹雼�. 鞝滌稖鞛愲姅 斓滉芳 3臧滌洈 雮� 毵る弰 靷嫟鞚� 鞐嗢潓鞚� 氤搓碃頃橁碃 牍勱车臧� 欤检殧 鞝曤炒臧� 鞐嗠嫟電� 響滌 歆勳垹鞚� 韽暔頃橁碃 鞛堨姷雼堧嫟.
Tenaya Therapeutics, Inc. (TNYA) a d茅pos茅 un avis Form 144 concernant une vente propos茅e de 5 053 actions ordinaires via Morgan Stanley Smith Barney Operations Department, pour une valeur marchande totale de 6 331,41 $. Le d茅p么t indique un nombre total d'actions en circulation de 162 976 102 et une date approximative de vente au 18/08/2025. Les titres 脿 vendre ont 茅t茅 acquis sous forme de Restricted Stock Units de l'茅metteur le 18/08/2025, avec un montant acquis de 13 750 unit茅s et une date de paiement le 18/08/2025. Le d茅clarant signale l'absence de ventes au cours des trois derniers mois et inclut la d茅claration standard concernant l'absence d'informations mat茅rielles non publiques.
Tenaya Therapeutics, Inc. (TNYA) hat eine Form-144-Mitteilung f眉r den geplanten Verkauf von 5.053 Stammaktien 眉ber die Morgan Stanley Smith Barney Operations Department eingereicht, mit einem Gesamtmarktwert von $6.331,41. Die Einreichung nennt die insgesamt ausstehenden Aktien mit 162.976.102 und ein ungef盲hres Verkaufsdatum 18.08.2025. Die zu ver盲u脽ernden Wertpapiere wurden am 18.08.2025 als Restricted Stock Units vom Emittenten erworben, der erworbene Betrag betr盲gt 13.750 Einheiten und das Zahlungsdatum ist 18.08.2025. Der Meldende berichtet 眉ber keine Verk盲ufe in den letzten drei Monaten und f眉gt die 眉bliche Erkl盲rung zur Abwesenheit nicht枚ffentlicher, wesentlicher Informationen bei.
FAQ
What does Tenaya Therapeutics' (TNYA) Form 144 disclose?
Where did the shares proposed for sale come from in the Form 144?
Does the filing report any securities sold in the past three months?
What is the approximate date of the proposed sale in the Form 144?
Which broker is named in the Form 144 for the proposed sale?
Does the Form 144 include a representation about material nonpublic information?
